Financial Ratios

CHANDRA BHAGAT PHARMA LTD.

NSE : NABSE : 542934ISIN CODE : INE07QQ01016Industry : Pharmaceuticals & DrugsHouse : Private
BSE114.850 (0 %)
PREV CLOSE ( ) 114.85
OPEN PRICE ( ) 114.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7000
TODAY'S LOW / HIGH ( )114.85 114.85
52 WK LOW / HIGH ( ) 80160
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.201.060.250.4210.27
   CEPS(Rs)1.351.110.410.461.38
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)35.1533.6832.5132.15199.21
   Tax Rate(%)22.0827.3231.9125.4822.26
Margin Ratios
   Core EBITDA Margin(%)2.662.925.213.324.32
   EBIT Margin(%)2.814.615.713.764.68
   Pre Tax Margin(%)0.971.170.390.450.83
   PAT Margin (%)0.760.850.270.330.65
   Cash Profit Margin (%)0.850.890.440.370.70
Performance Ratios
   ROA(%)1.361.100.260.400.98
   ROE(%)3.493.190.781.676.46
   ROCE(%)7.308.837.637.1613.40
   Asset Turnover(x)1.801.300.961.191.51
   Sales/Fixed Asset(x)91.1878.6056.3775.6785.91
   Working Capital/Sales(x)3.752.881.902.423.69
Efficiency Ratios
   Fixed Capital/Sales(x)0.010.010.020.010.01
   Receivable days35.3759.0276.0278.3175.83
   Inventory Days96.43134.43204.05170.53131.45
   Payable days9.8934.8377.4189.7389.27
Valuation Parameters
   PER(x)80.83107.78157.3495.880.00
   PCE(x)72.01102.8996.4187.050.00
   Price/Book(x)2.763.381.221.240.00
   Yield(%)0.000.000.000.00
   EV/Net Sales(x)0.721.080.770.640.30
   EV/Core EBITDA(x)24.6923.1813.0216.836.25
   EV/EBIT(x)25.5023.3813.4116.986.31
   EV/CE(x)1.411.400.750.800.38
   M Cap / Sales0.610.910.420.320.00
Growth Ratio
   Net Sales Growth(%)27.2133.07-24.78-11.579.50
   Core EBITDA Growth(%)-20.595.1516.50-29.04-4.48
   EBIT Growth(%)-22.467.3414.16-28.95-4.39
   PAT Growth(%)13.64319.54-39.67-54.29-33.39
   EPS Growth(%)13.65319.53-39.67-95.94-58.47
Financial Stability Ratios
   Total Debt/Equity(x)0.710.831.101.232.34
   Current Ratio(x)2.191.862.132.141.55
   Quick Ratio(x)1.110.961.060.850.71
   Interest Cover(x)1.531.341.071.141.22
   Total Debt/Mcap(x)0.260.250.910.99

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.